Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2021 | 04-2020 | 04-2019 | 04-2018 | 04-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,202 | 895 | 515 | 1,060 | 3,464 |
| TOTAL | $2,275 | $1,038 | $653 | $1,284 | $3,539 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 7 | 7 | 7 | 7 | 7 |
| TOTAL | $5,129 | $5,129 | $5,129 | $5,129 | $5,129 |
| Total Assets | $7,404 | $6,167 | $5,782 | $6,413 | $8,668 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 29 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 172 | 186 | 122 | 353 | 366 |
| Accrued Expenses | 553 | 817 | 621 | 292 | 215 |
| TOTAL | $725 | $1,031 | $743 | $644 | $580 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 46 | N/A | N/A | N/A |
| TOTAL | $N/A | $46 | $N/A | $N/A | $N/A |
| Total Liabilities | $725 | $1,078 | $743 | $644 | $580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,612 | 1,634 | 930 | 729 | 681 |
| Common Shares | 0 | 0 | 119 | 101 | 91 |
| Retained earnings | -107,410 | -103,858 | -100,031 | -95,964 | -89,135 |
| Other shareholders' equity | -20 | -22 | -14 | -5 | 2 |
| TOTAL | $6,680 | $5,089 | $5,040 | $5,769 | $8,087 |
| Total Liabilities And Equity | $7,404 | $6,167 | $5,782 | $6,413 | $8,667 |